PlainRecalls
FDA Drug Moderate Class II Terminated

WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5750-2 ; b) 30 Tablets, NDC 64727-5750-4; c) 60 Tablets, NDC 64727-5750-5; d) 90 Tablets, NDC 64727-5750-6; e) 100 Tablets, NDC 64727-5750-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

Reported: September 23, 2020 Initiated: August 25, 2020 #D-1609-2020

Product Description

WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5750-2 ; b) 30 Tablets, NDC 64727-5750-4; c) 60 Tablets, NDC 64727-5750-5; d) 90 Tablets, NDC 64727-5750-6; e) 100 Tablets, NDC 64727-5750-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

Reason for Recall

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Details

Recalling Firm
RLC Labs Inc.
Units Affected
N/A
Distribution
Nationwide in the United States
Location
Phoenix, AZ

Frequently Asked Questions

What product was recalled?
WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5750-2 ; b) 30 Tablets, NDC 64727-5750-4; c) 60 Tablets, NDC 64727-5750-5; d) 90 Tablets, NDC 64727-5750-6; e) 100 Tablets, NDC 64727-5750-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034. Recalled by RLC Labs Inc.. Units affected: N/A.
Why was this product recalled?
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 23, 2020. Severity: Moderate. Recall number: D-1609-2020.